Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 841 AL 855

Review: the ubiquitin-proteasome system: contributions to cell death or survival in neurodegeneration

Rogers N, Paine S, Bedford L, Layfield R.

Neuropathol Appl Neurobiol. 2010 Apr;36(2):113-24. doi: 10.1111/j.1365-2990.2010.01063.x. Epub 2010 Feb 19.

Review: autophagy and neurodegeneration: survival at a cost?

Cherra SJ 3rd, Dagda RK, Chu CT.

Neuropathol Appl Neurobiol. 2010 Apr;36(2):125-32. doi: 10.1111/j.1365-2990.2010.01062.x. Epub 2010 Feb 19.

Kleptomania, an unusual impulsive control disorder in Parkinson's disease?

Bonfanti AB, Gatto EM.

Parkinsonism Relat Disord. 2010 Jun;16(5):358-9. doi: 10.1016/j.parkreldis.2010.02.004. Epub 2010 Mar 4.

Responsiveness of the EQ-5D and 8-item Parkinson's Disease Questionnaire (PDQ-8) in a 4-year follow-up study

Luo N, Ng WY, Lau PN, Au WL, Tan LC.

Qual Life Res. 2010 May;19(4):565-9. doi: 10.1007/s11136-010-9615-7. Epub 2010 Mar 4.

Differential effects of divalent manganese and magnesium on the kinase activity of leucine-rich repeat kinase 2 (LRRK2)

Lovitt B, Vanderporten EC, Sheng Z, Zhu H, Drummond J, Liu Y.

Biochemistry. 2010 Apr 13;49(14):3092-100. doi: 10.1021/bi901726c.

Effects of dance on balance and gait in severe Parkinson disease: a case study

Hackney ME, Earhart GM.

Disabil Rehabil. 2010;32(8):679-84. doi: 10.3109/09638280903247905.

Protein conformational pathology in Alzheimer's and other neurodegenerative diseases; new targets for therapy

Zerovnik E.

Curr Alzheimer Res. 2010 Feb;7(1):74-83. doi: 10.2174/156720510790274437.

GM1 ganglioside in Parkinson's disease: Results of a five year open study

Schneider JS, Sendek S, Daskalakis C, Cambi F.

J Neurol Sci. 2010 May 15;292(1-2):45-51. doi: 10.1016/j.jns.2010.02.009. Epub 2010 Mar 5.

Clinical presentation and treatment of atrial fibrillation in Wolff-Parkinson-White syndrome

Thanavaro JL, Thanavaro S.

Heart Lung. 2010 Mar-Apr;39(2):131-6. doi: 10.1016/j.hrtlng.2009.06.011. Epub 2009 Aug 25.

Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress

Abdulwahid Arif I, Ahmad Khan H.

Toxicol Ind Health. 2010 Mar;26(2):121-8. doi: 10.1177/0748233710362382.

Cerebral infratentorial large B-cell lymphoma presenting as Parkinsonism

Lin CM, Hong K.

Tohoku J Exp Med. 2010 Mar;220(3):187-90. doi: 10.1620/tjem.220.187.

Oligomeric alpha-synuclein and its role in neuronal death

Brown DR.

IUBMB Life. 2010 May;62(5):334-9. doi: 10.1002/iub.316.

Stem cell-derived dopamine neurons for brain repair in Parkinson's disease

Fricker-Gates RA, Gates MA.

Regen Med. 2010 Mar;5(2):267-78. doi: 10.2217/rme.10.3.

Behavioral phenotyping of mouse models of Parkinson's disease

Taylor TN, Greene JG, Miller GW.

Behav Brain Res. 2010 Jul 29;211(1):1-10. doi: 10.1016/j.bbr.2010.03.004. Epub 2010 Mar 6.

Increased melanoma risk in Parkinson disease: a prospective clinicopathological study

Bertoni JM, Arlette JP, Fernandez HH, Fitzer-Attas C, Frei K, Hassan MN, Isaacson SH, Lew MF, Molho E, Ondo WG, Phillips TJ, Singer C, Sutton JP, Wolf JE Jr; North American Parkinson's and Melanoma Survey Investigators.

Arch Neurol. 2010 Mar;67(3):347-52. doi: 10.1001/archneurol.2010.1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias